breast cancer

AstraZeneca caps milestone week with FDA nod, COPD data

AstraZeneca secured accelerated FDA approval for its breast cancer drug Etcamah (camizestrant), capping a week of clinical milestones for the British-Swedish drugmaker that included positive late-stage data for a COPD treatment it expects could generate more than $5 billion in…

WHO report finds vast gap in breast cancer survival

The World Health Organization published the first-ever global breast cancer survival estimates on July 8, showing that a woman's chance of surviving the disease depends heavily on where she lives and how much her country earns. The data, released alongside…

Scientists find 81 hidden genes driving deadly breast cancer

A team of scientists at Sinai Health in Toronto has uncovered 81 previously unknown genes involved in basal-like triple-negative breast cancer, solving a long-standing mystery of how chromosomal chaos fuels one of the disease's deadliest forms. The findings, published in…

FDA approves Trodelvy for first-line metastatic breast cancer

The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences' Trodelvy (sacituzumab govitecan-hziy) for the first-line treatment of metastatic triple-negative breast cancer, a decision that establishes the antibody-drug conjugate as a new standard of care for one of the…